Literature DB >> 8806545

Suppression of lymphocytic choriomeningitis virus--induced growth hormone deficiency syndrome by disease-negative virus variants.

M N Teng1, M B Oldstone, J C de la Torre.   

Abstract

Populations of RNA viruses consist of heterogeneous mixtures of related genomes (quasispecies). Isolation of variants present at low levels within a population can result in clonal virus populations which display markedly different phenotypes upon infection of the host. The mechanisms by which these variants are maintained within the original quasispecies are not understood. Certain strains of lymphocytic choriomeningitis virus (LCMV) cause a growth hormone deficiency syndrome (GHDS) when inoculated into newborn C3H/St mice while others do not. We have previously described the isolation of virus clones from the GHDS-negative WE strain of LCMV which differ in their ability to cause GHDS. To investigate how disease-positive clones can remain hidden within a disease-negative parental population, we examined whether infection with mixtures of the GHDS-negative (WE c54) and GHDS-positive (WE c2.5) clones could cause GHDS. Neonatal C3H/ST mice infected with 100:1 or 10:1 ratios of WE c54 to WE c2.5 did not develop the syndrome, while animals infected with 1:1 or lower ratios did. Development of GHDS correlated with the extent to which the GH-producing cells of the anterior pituitary were infected. These data indicate that a large excess of disease-negative clones can restrict the replication of disease-positive clones in GH-producing cells, thus preventing the onset of GHDS. In addition, our results indicate that a threshold for phenotypic dominance exists. Interestingly, WE c54 did not entirely outcompete WE c2.5 in mice infected with the 100:1 ratio, suggesting a mechanism whereby pathogenic viruses can be maintained within a nonpathogenic viral population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806545     DOI: 10.1006/viro.1996.0460

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Probability of fixation of an advantageous mutant in a viral quasispecies.

Authors:  Claus O Wilke
Journal:  Genetics       Date:  2003-02       Impact factor: 4.562

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Mutagenesis-induced, large fitness variations with an invariant arenavirus consensus genomic nucleotide sequence.

Authors:  Ana Grande-Pérez; Gema Gómez-Mariano; Pedro R Lowenstein; Esteban Domingo
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Hidden virulence determinants in a viral quasispecies in vivo.

Authors:  Marta Sanz-Ramos; Fayna Díaz-San Segundo; Cristina Escarmís; Esteban Domingo; Noemí Sevilla
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

5.  A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL.

Authors:  Brian C Ware; Brian M Sullivan; Stephanie LaVergne; Brett S Marro; Toru Egashira; Kevin P Campbell; John Elder; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

Review 6.  Origin and evolution of viruses.

Authors:  J Holland; E Domingo
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 7.  Viral quasispecies.

Authors:  Raul Andino; Esteban Domingo
Journal:  Virology       Date:  2015-03-29       Impact factor: 3.616

Review 8.  Quasispecies and virus.

Authors:  Esteban Domingo; Celia Perales
Journal:  Eur Biophys J       Date:  2018-02-03       Impact factor: 1.733

9.  Mechanisms controlling virulence thresholds of mixed viral populations.

Authors:  Karen Z Lancaster; Julie K Pfeiffer
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

10.  Preextinction viral RNA can interfere with infectivity.

Authors:  Claudia González-López; Armando Arias; Nonia Pariente; Gema Gómez-Mariano; Esteban Domingo
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.